Retrospective analysis of the safety and efficacy of vandetanib as systemic treatment for patients with advanced and progressive medullary thyroid cancer (MTC)

被引：0
|
作者：
Capdevila, Jaume
Martinez-Trufero, Javier
Dalmau, Elsa
Alvarez-Escala, Cristina
Beltran, Miguel
Duran, Manuel
Gallegos, Isabel
Luis Manzano, Jose
Mesla, Ricard
Pajares, Isabel
Fuentes Pradera, Jose
Grau, Juan J.
Reig, Oscar
Manuel Trigo, Jose
Grande, Enrique
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
[2] Hosp Miguel Servet, Zaragoza, Spain
[3] Univ Autonoma Barcelona, Corp Sanitaria Univ Parc Tauli, Sabadell, Spain
[4] La Paz Univ Hosp, Dept Endocrinol, Madrid, Spain
[5] Hosp Univ Josep Trueta, Inst Catala Oncol, Girona, Spain
[6] Rey Juan Carlos Univ Hosp, Madrid, Spain
[7] Hosp Gen Segovia, Segovia, Spain
[8] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[9] Catalan Inst Oncol, Barcelona, Spain
[10] Hosp Univ Miguel Servet, Zaragoza, Spain
[11] Hosp Univ Virgen de Valme, Seville, Spain
[12] Hosp Clin Barcelona, Barcelona, Spain
[13] Hosp Univ Virgen de la Victoria, Malaga, Spain
[14] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17016
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Enrique Grande
    Michael C. Kreissl
    Sebastiano Filetti
    Kate Newbold
    Walter Reinisch
    Caroline Robert
    Martin Schlumberger
    Lærke K. Tolstrup
    Jose L. Zamorano
    Jaume Capdevila
    Advances in Therapy, 2013, 30 : 945 - 966
  • [42] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Grande, Enrique
    Kreissl, Michael C.
    Filetti, Sebastiano
    Newbold, Kate
    Reinisch, Walter
    Robert, Caroline
    Schlumberger, Martin
    Tolstrup, Laerke K.
    Zamorano, Jose L.
    Capdevila, Jaume
    ADVANCES IN THERAPY, 2013, 30 (11) : 945 - 966
  • [43] VANDETANIB IN LOCALLY ADVANCED OR METASTATIC MEDULLARY THYROID CANCER (MTC): A RANDOMIZED, DOUBLE-BLIND PHASE III TRIAL (ZETA)
    Wells, S. A.
    Robinson, B. G.
    Gagel, R. F.
    Dralle, H.
    Fagin, J. A.
    Santoro, M.
    Baudin, E.
    Vasselli, J.
    Read, J.
    Schlumberger, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 315 - 315
  • [44] Treatment of advanced medullary thyroid cancer
    Smit J.
    Thyroid Research, 6 (Suppl 1)
  • [45] Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
    Werner, R. A.
    Schmid, J. S.
    Muegge, D. O.
    Lueckerath, K.
    Higuchi, T.
    Haenscheid, H.
    Grelle, I.
    Reiners, C.
    Herrmann, K.
    Buck, A. K.
    Lapa, C.
    MEDICINE, 2015, 94 (45) : e2016
  • [46] Safety of denosumab in patients with refractory differentiated thyroid cancer and advanced medullary thyroid cancer.
    Wassermann, Johanna
    Mathy, Elise
    Lescaille, Geraldine
    Slim, Marine
    Buffet, Camille
    Saie, Clotilde
    Braik-Djellas, Yasmin
    Simon, Jean-Marc
    Menegaux, Fabrice
    Tresallet, Christophe
    Chami, Linda
    Lussey-Lepoutre, Charlotte
    Herve, Genevieve
    Bernier, Marie-Odile
    Spano, Jean-Philippe
    Leenhardt, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
    Capdevila, Jaume
    Trigo Perez, Jose Manuel
    Aller, Javier
    Luis Manzano, Jose
    Garcia Adrian, Silvia
    Zafon, Carles
    Reig, Oscar
    Bohn, Uriel
    Cillan, Elena
    Duran, Manuel
    Gonzalez Astorga, Beatriz
    Lopez, Ana
    Javier, Medina
    Porras, Ignacio
    Reina, Juan J.
    Palacios, Nuria
    Grande, Enrique
    Grau, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
    Capdevila, Jaume
    Manuel Trigo, Jose
    Aller, Javier
    Luis Manzano, Jose
    Garcia Adrin, Silvia
    Zafon Llopis, Carles
    Reig, Oscar
    Bohn, Uriel
    Ramon y Cajal, Teresa
    Duran-Poveda, Manuel
    Gonzalez Astorga, Beatriz
    Lopez-Alfonso, Ana
    Medina Martinez, Javier
    Porras, Ignacio
    Jose Reina, Juan
    Palacios, Nuria
    Grande, Enrique
    Cillan, Elena
    Matos, Ignacio
    Jose Grau, Juan
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 177 (04) : 309 - 317
  • [49] Systemic treatment of advanced differentiated and medullary thyroid cancer Overview and practical aspects
    Kreissl, M. C.
    Fassnacht, M.
    Mueller, S. P.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 88 - 93
  • [50] Systemic treatment of advanced, metastatic, medullary thyroid carcinoma
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Cappagli, Virginia
    Lorusso, Loredana
    Bottici, Valeria
    Elisei, Rossella
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
12345